The term "lipid triad" or "atherogenic lipoprotein phenotype" has been introduced to describe a common form of dyslipidemia, characterized by three lipid abnormalities: increased plasma …

Background: Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol and are favoured …

Aug 21, 2020 · Feldman's view of the "lipid triad" suggests that in the context of high-HDL/low-TGs, the larger LDL particle size means LDL has a lower atherogenic potential. However, the …

Aug 9, 2022 · Two relevant forms of lipid abnormalities are atherogenic dyslipidaemia (AD) and lipid triad (LT), which involve alterations in triglyceride levels, HDL-c, and LDL-c. The aim of …

Apr 27, 2023 · A relationship between atherogenic dyslipidaemia and the three insulin resistance risk scales assessed is revealed, with higher IR mean values and prevalence in people with …

The lipid triad refers basically to three lipid abnormalities: increased plasma triglycerides and small dense low density lipoprotein (sd-LDL), and decreased high density lipoprotein …

Based on the main alterations in lipid profile, comprising increased TG levels, reduced concentrations of high-density lipoprotein cholesterol (HDL-C), and elevated sdLDL particles, …

Even though modification of the atherogenic lipid triad is probably one of the most effective methods of reducing cardiovascular risk, therapy for diabetic dyslipidemia is often directed to …

The lipid triad composed of elevated LDL, low HDL, and high TG levels is traditionally believed to lead to increased development of CVD.

lipid triad. Third, since high triglyceride levels also commonly associate with hypertension, insulin re-sistance (with or without glucose intolerance), and a prothrombotic state, they could be a …